FDA Proposes Study Examining Risk Information in DTC Ads

Drug Industry Daily
A A
The FDA plans to launch a study examining how consumers view risk information in direct-to-consumer (DTC) prescription drug advertisements, the latest study delving into how drugmakers craft ads.

To View This Article:

Login

Subscribe To Drug Industry Daily